Growth factors in human ovarian cancer

Cancer Treatment Reviews

Volumn 23, Issue 2, 1997, Pages 113-131

  Westermann, A M ^a   Beijnen, J H ^a   Moolenaar, W H ^a   Rodenhuis, S ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; BASIC FIBROBLAST GROWTH FACTOR; COLONY STIMULATING FACTOR 1; CYTOKINE; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; LYSOPHOSPHATIDIC ACID; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

CANCER GROWTH; CLONOGENIC ASSAY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; OVARY CANCER; OVARY CARCINOMA; REVIEW; TUMOR BIOPSY;

EID: 0030749693     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-7372(97)90024-4     Document Type: Article

References (137)

1. Ozols, R. F., Rubin, S. C., Dembo, A. J., & Robboy, S. J. (1992) Epithelial ovarian cancer. In: Hoskins, W. J., Perez, C. A. & Young, R. C. eds, Principles and Practice of Gynecologic Oncology, First edition. Philadelphia, PA: Lippincott, pp. 732-781.
2. Moolenaar, W. H., Van der Bend, R. L., Van Corven, E. J., Jalink, K. Eichholtz, T. & Van Blitterswijk, W. J. (1992) Lysophosphatidic acid: a novel phospholipid with hormone- and growth factor-like activities. Cold Spring Harb. Symp. Quant. Biol. 17: 163-167.
3. DiSaia, P. J., Morrow, M., Kanabus, J., Piechal, W. & Townsend, D. E. (1975) Two new tissue cultures lines from ovarian cancer. Gyn. Oncol. 3: 215-219.
4. Freedman, R. S., Pihl, E., Kusyk, C., Gallager, H. S. & Rutledge, F. (1978) Characterization of an ovarian carcinoma cell line. Cancer 42: 2352-2359.
5. Kanabus, J., Braunstein, G. D., Emry, P. K., DiSaia, P. J. & Wade, M. E. (1978) Kinetics of growth and ectopic production of human chorionic gonadotropin by an ovarian cystadenocarcinoma cell line maintained in vitro. Cancer Res. 38: 765-770.
6. Pattillo, R. A., Story, M. T. & Ruckert, A. C. F. (1979) Expression of cell-mediated immunity and blocking factor using a new line of ovarian cancer cells in vitro. Cancer Res. 39: 1185-1191.
7. Abu Sinna, G., Beckman, G., Lundgren, E., Nordenson, I. & Roos, G. (1979) Characterization of two new human ovarian carcinoma cell lines. Gyn. Oncol. 7: 267-280.
8. Woods, L. K., Morgan, R. T., Quinn, L. A., Moore, G. E., Semple, T. U. & Stedman, K. E. (1979) Comparison of four new cell lines from patients with adenocarcinoma of the ovary. Cancer Res. 39: 4449-4459.
9. Hamilton, T. C., Young, R. C., McKoy, W. M. et al. (1983) Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res. 43: 5379-5389.
10. Simon, W. E., Albrecht, M., Haensel, M., Dietel, M. & Hoelzel, F. (1983) Cell lines derived from human ovarian carcinomas: growth stimulation by gonadotrophic and steroid hormones. J. Natl. Cancer Inst. 70: 839-845.
11. Wilson, A. P. (1984) Characterization of a cell line derived from the ascites of a patient with papillary serous cystadenocarcinoma of the ovary. J. Natl. Cancer Inst. 72: 513-521.
12. Buick, R. N., Pullano, R. & Trent, J. M. (1985) Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res. 45: 3668-3676.
13. Clamon, G., Loh, P.-M., White, M. & Robinson, R. (1985) Development and characterization of a human ovarian cancer cell line which clones without agar in vitro. Gynecol. Oncol. 20: 92-99.
14. Benard, J., Da Silva, J., de Blois, M.-C. et al. (1985) Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice. Cancer Res. 45: 4970-4979.
15. Hill, B. T, Whelan, R. D. H., Gibby, E. M. et al. (1987) Establishment and characterization of three new human ovarian carcinoma cell lines and initial evaluation of their potential in experimental chemotherapy studies. Int. J. Cancer 39: 219-225.
16. Ishiwata, I., Ishiwata, C., Soma, M., Nozawa, S. & Ishikawa, H. (1987) Characterization of newly established human ovarian carcinoma cell line: special reference of the effects of cis-platinum on cellular proliferation and release of CA 125. Gynecol. Oncol. 26: 340-354.
17. Langdon, S. P., Lawrie, S. S., Hay, F. G. et al. (1988) Characterization and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res. 48: 6166-6172.
18. Briers, T. W., Stroobants, P., Vandeputte, T. M. et al. (1989) Establishment and characterization of a human ovarian neoplastic cell line DO-s. Cancer Res. 49: 5153-5161.
19. Crickard, K., Niedbala, M. J., Crickard, U. et al. (1989) Characterization of human ovarian and endometrial carcinoma cell lines established on extracellular matrix. Gynecol. Oncol. 32: 163-173.
20. Golombick, T., Dansey, R., Bezwoda, W. R. & Rosendorff, J. (1990) Establishment and characterization of two new human ovarian cancer cell lines UWOV1 and UWOV2 and a subline UWOV2 (Sf) growing in serum-free conditions: growth characteristics, biochemical and cytogenetic studies. In Vitro Cell. Dev. Biol. 26: 447-454.
21. Yamada, T., Ueda, M., Otsuki, Y, Ueki, M. & Sugimoto, O. (1991) Establishment and characterization of a cell line (OMC-3) originating from a human mucinous cystadenocarcinoma of the ovary. Gynecol. Oncol. 40: 118-128.
22. Jozan, S., Roche, H., Cheutin, F., Carton, M. & Salles, B. (1992) New human ovarian cancer cell line OVCCRI/sf in serum-free medium. In Vitro Cell. Dev. Biol. 28A: 687-689.
23. Hirte, H. W., Kaiser, J. S. & Bacchetti, S. (1994) Establishment and characterization of four human epithelial ovarian carcinoma cell lines. Cancer 74: 900-906.
24. Turner, J. T. & Wyche, J. H. (1980) Regulation of metastatic ovarian cells in serum-free medium by epidermal growth factor and transferrin. J. Cell. Physiol. 104: 233-240.
25. Golombick, T., Dajee, D. R. & Bezwoda, W. R. (1985) Extracellular matrix interactions 1: production of extracellular matrix with attachment and growth-sustaining functions by UWOV2 ovarian cancer cells growing in protein-free conditions. In Vitro Cell. Dev. Biol. 31: 387-395.
26. Berchuck, A., Olt, G. J., Everitt, L., Soisson, A. P., Bast, R. C. & Boyer, C. M. (1990) The role of peptide growth factors in epithelial ovarian cancer. Obstet. Gynecol. 75: 255-262.
27. loachim, H. L., Sabbath, M., Andersson, B. & Barber, H. R. K. (1974) Tissue cultures of ovarian carcinomas. Lab Invest. 31: 381-390.
28. Hamburger, A. W. & Salmon, S. E. (1977) Primary bioassay of human tumor stem cells. Science 197: 461-463.
29. Hamburger, A. W., Salmon, S. E., Kim, M. B. et al. (1978) Direct cloning of human ovarian carcinoma cells in agar. Cancer Res. 38: 3438-3443.
30. Hamburger, A. W., Salmon, S. E. & Alberts, D.S. (1980) Development of a bioassay for ovarian carcinoma colony-forming cells. Progress in Clin. Biol. Res. 48: 63-73.
31. Welander, C. E., Natale, R. B. & Lewis, J. L. (1982) In vitro growth of human ovarian cancer cells by xenogeneic peritoneal macrophages. J. Natl. Cancer Inst. 69: 1039-1042.
32. Ozols, R. F., Willson, J. K. V., Grotzinger, K. R. & Young, R. C. (1980) Cloning of human ovarian cancer cells in soft agar from malignant effusions and peritoneal washings. Cancer Res. 40: 2743-2747.
33. Hamburger, A. W., White, C. P., Dunn, F. E., Citron, M. L. & Hummel, S. (1983) Modulation of human tumor colony growth in soft agar by serum. Int. J. Cell Cloning 1: 216-229.
34. Carney, D. N., Bunn, P. A., Gazdar, A. F., Pagan, J. A. & Minna, J. D. (1981) Selective growth in serum-free hormone-supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung. Proc. Natl. Acad. Sci. USA 78: 3185-3189.
35. Sporn, M. B. & Roberts, A. B. (1988) Peptide growth factors are multifunctional. Nature 332: 217-218.
36. Sporn, M. B. & Roberts, A. B. (1985) Autocrine growth factors and cancer. Nature 313: 745-747.
37. Cohen, S. & Carpenter, G. (1975) Human epidermal growth factor: isolation and chemical and biological properties. Proc. Natl. Acad. Sci. USA 72: 1317-1321.
38. Broxterman, H. J., Sprenkels-Schotte, C., Engelen, Ph., Levya, A. & Pinedo, H. M. (1987) Analysis of human ascites effect on clonogenic growth of human tumor cell lines and NRK-49F cells in soft agar. Int. J. Cell Cloning 5: 158-169.
39. Zhou, L. & Leung, B. S. (1992) Growth regulation of ovarian cancer cells by epidermal growth factor and transforming growth factor α and β1. Biochim. Biophys. Acta 1080: 130-136.
40. Kurachi, H., Morishige, K., Amemiya, K. et al. (1991) Importance of transforming growth factor α/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vivo. Cancer Res. 51: 5956-5959.
41. Crew, J. A., Langdon, S. P., Miller, E. P. & Miller, W. R. (1992) Mitogenic effects of epidermal growth factor and transforming growth factor-α on EGF-receptor positive human ovarian carcinoma cell lines. Eur. J. Cancer 28: 337-341.
42. Jozan, S., Guerrin, M., Mazars, P. et al. (1992) Transforming growth factor β1 (TGF-β1) inhibits growth of a human ovarian carcinoma cell line (OVCCR1) and is expressed in human ovarian tumors. Int. J. Cancer 52: 766-770.
43. Hamburger, A. W., White, C. P. & Brown, R. W. (1981) Effect of epidermal growth factor on proliferation of human tumor cells in soft agar. J. Natl. Cancer Inst. 67: 825-829.
44. Pathak, M. A., Matrisian, L. M., Magun, B. E. & Salmon, S. E. (1982) Effect of epidermal growth factor on clonogenic growth of primary human tumor cells. Int. J. Cancer 30: 745-750.
45. Singletary, S. E., Baker, F. L., Spitzer, G. et al. (1987) Biological effect of epidermal growth factor on the in vitro growth of human tumors. Cancer Res. 47: 403-406.
46. Wimalasena, J., Dostal, R. & Meehan, D. (1992) Gonadotropins, Estradiol, and growth factors regulate epithelial ovarian cancer cell growth. Gynecol. Oncol. 46: 345-350.
47. Todaro, G. J., Fryling, C. & De Larco, J. E. (1980) Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc. Natl. Acad. Sci USA 77: 5258-5262.
48. Shoyab, M., Plowman, G. D., McDonald, V. L, Bradley, J. G. & Todaro, G. J. (1988) Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science 243: 1074-1076.
49. Yamamoto, T., Ikawa, S., Akiyama, T. et al. (1986) Similarity of protein encoded by human c-erbB2 gene to epidermal growth factor receptor. Nature 319: 230-234.
50. Lupu, R., Colomer, R., Zugmaier, G. et al. (1990) Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2. Science 249: 1552-1555.
51. Kraus, M. H., lssing, W., Miki, T., Popescu, N. C. & Aaronson, S. A. (1989) Isolation and characterization of erbB3, a third member of the erbB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc. Natl. Acad. Sci. USA 86: 9193-9197.
52. erbB4, a fourth member of the epidermal growth factor receptor family. Proc. Natl. Acad. Sci. USA 90: 473-475.
53. Simpson, B. J. B., Phillips, H. A., Lessells, A. M. et al. (1995) c-erbB growth-factor-receptor proteins in ovarian tumours. Int. J. Cancer 64: 202-206.
54. Roberts, A. B., Anzano, M. A., Lamb, L C., Smith, J. M. & Sporn, M. B. (1981) New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc. Natl. Acad. Sci. USA 78: 5339-5343.
55. Bauknecht, T., Kiechle, M., Bauer, G. & Siebers, J. W. (1986) Characterization of growth factors in human ovarian carcinomas. Cancer Res. 46: 2614-2618.
56. Ottensmeier, C., Swanson, L., Strobel, T., Druker, B., Niloff, J. & Cannistra, S. A. (1996) Absence of constitutive EGF receptor activation in ovarian cancer cell lines. Br. J. Cancer74(3): 446-452.
57. Stromberg, K., Collins, T. J., Gordon, A. W., Jackson, C. L. & Johnson, G. R. (1992) Transforming growth factor β acts as an autocrine growth factor in ovarian carcinoma cell lines. Cancer Res. 52: 341-347.
58. Hanauske, A.-R., Arteaga, C. L., Clark, G. M. et al. (1988) Determination of transforming growth factor activity in effusions from cancer patients. Cancer 61: 1832-1837.
59. Morishige, K., Kurachi, H., Amemiya, K. et al. (1991) Evidence for the involvement of transforming growth factor α and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro. Cancer Res. 51: 5322-5328.
60. Gordon, A. W., Pegues, J. C., Johnson, G. R., Kannan, B., Auersperg, N. & Stromberg, K. (1995) mRNA phenotyping of the major ligands and receptors of the EGF supergene family in human ovarian epithelial cells. Cancer Lett. 89: 63-71.
61. Kurachi, H., Morishige, K., Adachi, H. et al. (1994) Implantation and growth of epidermal growth factor (EGF) receptor expressing human ovarian cancer xenografts in nude mice is dependent on EGF. Cancer 74: 2984-2990.
62. Slamon, D. J., Godolphin, W., Jones, L. A. et al. (1989) Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science 244: 707-712.
63. Haldane, J. S., Hird, V., Hughes, C. M. & Gullick, W. J. (1990) c-erbB-2 oncogene expression in ovarian cancer. J. Pathol. 162: 231-237.
64. Hung, M.-C., Zhang, X., Van, D.-H. et al. (1992) Aberrant expression of the c-erbB-2/neu protooncogene in ovarian cancer. Cancer Lett. 61: 95-103.
65. Johnson, G. R., Saeki, T., Auersperg, N. et al. (1991 ) Response to and expression of amphiregulin by ovarian carcinoma and normal ovarian surface epithelial cells: nuclear localization of endogenous amphiregulin. Biochem. Biophys. Res. Com. 180: 481-488.
66. Roberts, A. B., Anzano, M. A., Lamb, L. C. et al. (1982) Isolation from murine sarcoma cells of novel transforming growth factors potentiated by EGF. Nature 295: 417-419.
67. Anzano, M. A., Roberts, A. B., Meyers, C. A. et al. (1982) Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells. Cancer Res. 42: 4776-4778.
68. Moses, H. L, Yang, Y. Y. & Pietenpol, J. A. (1990) TGF-β stimulation and inhibition of proliferation: new mechanistic insights. Cell 63: 245-247.
69. Massague, J. (1992) Receptors for the TGF-β family. Cell 69: 1067-1070.
70. Berchuck, A., Rodriguez, G., Olt, G. et al. (1992) Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-β. Am. J. Obstet. Gynecol. 166: 676-684.
71. Marth, C., Lang, T., Koza, A., Mayer, I. & Daxenbichler, G. (1990) Transforming growth factor-beta and ovarian carcinoma cells: regulation of proliferation and surface antigen expression. Cancer Lett. 51: 221-225.
72. Bartlett, J. M. S., Rabiasz, G. J., Scott, W. N., Langdon, S. P., Smyth, J. F. & Miller, W. R. (1992) Transforming growth factor-β mRNA expression and growth control of human ovarian carcinoma cells. Br. J. Cancer 65: 655-660.
73. Hurteau, J., Rodriguez, G. C., Whitaker, R. S. et al. (1994) Transforming growth factor-beta inhibits proliferation of human ovarian cancer cells obtained from ascites. Cancer 74: 93-99.
74. Henriksen, R., Gobl, A., Wilander, E., Oberg, K., Miyazono, K. & Funa, K. (1995) Expression and prognostic significance of TGF-β isotypes, latent TGF-β1 binding protein, TGF-β type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms. Lab. Invest. 73: 213-220.
75. Golombick, T., Dajee, D. & Bezwoda, W. R. (1995) Extracellular matrix interactions 2: extracellular matrix structure is important for growth factor localization and function. In Vitro Cell. Dev. Biol. 31: 396-403.
76. Ross, R., Raines, E. W. & Bowen-Pope, D. F. (1986) The biology of platelet-derived growth factor. Cell 46: 155-169.
77. Westermark, B. & Heldin, C.-H. (1991) Platelet-derived growth factor in autocrine transformation. Cancer Res. 51: 5087-5092.
78. Versnel, M. A., Haarbrink, M., Langerak, A. W., De Laat, P. A. J. M., Hagemeijer, A. & Van der Kwast, T. H. (1994) Human ovarian tumors of epithelial origin express PDGF in vitro and in vivo. Cancer Genet. Cytogenet. 73: 60-64.
79. Henriksen, R., Funa, K., Wilander, E., Backstrom, T., Ridderheim, M. & Oberg, K. (1993) Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms. Cancer Res. 53: 4550-4554.
80. Burgess, W. H. & Maciag, T. (1989) The heparin-binding (fibroblast) growth factor family or proteins. Annu. Rev. Biochem. 58: 575-606.
81. Goldfarb, M. (1990) The fibroblast growth factor family. Cell Growth Diff. 1: 439-445.
82. Crickard, K., Gross, J. L., Crickard, U. et al. (1994) Basic fibroblast growth factor and receptor expression in human ovarian cancer. Gynecol. Oncol. 55: 277-284.
83. Macaulay, V. M. (1992) Insulin-like growth factors and cancer. Br. J. Cancer 65: 311-320.
84. Yee, D., Morales, F. R., Hamilton, T. C. & Von Hoff, D. D. (1991) Expression of insulin-like growth factor I, its binding proteins, and its receptor in ovarian cancer. Cancer Res. 51: 5107-5112.
85. Karasik, A., Menczer, J., Pariente, C. & Kanety, H. (1994) Insulin-like growth factor-1 (IGF-1) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer. J. Clin Endocrinol. Metab. 78(2): 271-276.
86. Resnicoff, M., Ambrose, D., Coppola, D. & Rubin, R. (1993) Insulin-like growth factor-1 and its receptor mediate the autocrine proliferation of human ovarian carcinoma cell lines. Lab. Invest. 69(6): 756-760.
87. Aggarwal, B. B. & Pocsik, E. (1992) Cytokines: from clone to clinic. Arch. Biochem. Biophys. 292: 335-359.
88. Iversen, O. H. (1991) The hunt for endogenous growth-inhibitory and/or tumor suppression factors: their role in physiological and pathological growth regulation. Adv. Cancer Res. 57: 413-453.
89. Malik, S. & Balkwill, F. (1991) Epithelial ovarian cancer: a cytokine propelled disease? Br. J. Cancer 64: 617-620.
90. Pennica, D., Nedwin, G. E., Hayflick, J. S. et al. (1984) Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312: 724-729.
91. Naylor, M. S., Malik, S. T. A., Stamp, G. W. H., Jobling, T. & Balkwill, F. R. (1990) In situ detection of tumour necrosis factor in human ovarian cancer specimens. Eur. J. Cancer 26: 1027-1030.
92. Naylor, M. S., Burke, F. & Balkwill, F. R. (1995) Cytokines and ovarian cancer. In: Sharp, F., Mason, P., Blackett, T. & Berek, J. eds, Ovarian Cancer 3, 1st edition. London: Chapman & Hall Medical, pp. 89-97.
93. Wu, S., Boyer, C. M., Whitaker, R. S. et al. (1993) Tumor necrosis factor α as an autocrine and paracrine growth factor for ovarian cancer monokine induction of tumor cell proliferation and tumor necrosis factor α expression. Cancer Res. 53: 1939-1944.
94. Giavazzi, R., Garofalo, A., Bani, M. R. et al. (1990) Interleukin-1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res. 50: 4771-4775.
95. Watson, J., Sensintaffar, J. L., Berek, J. S. & Martinez-Maza, O. (1990) Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res. 50: 6959-6965.
96. Lidor, Y. J., Xu, F. I., Martinez-Maza, O. et al. (1993) Constitutive production of macrophage colony stimulating factor and IL-6 by human ovarian surface epithelial cells. Exp. Cell Res. 207: 332-339.
97. Wu, S., Rodabaugh, K., Martinez-Maza, O. et al. (1992) Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-alpha. Am J. Obstet. Gynecol. 166: 997-1007.
98. Ramakrishan, S., Xu, F. J., Brandt, S. J., Niedel, J. E., Bast, R. C. & Brown, E. L. (1989) Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines. J. Clin Invest. 83: 921-926.
99. Kacinski, B. M., Carter, D., Mittal, K. et al. (1990) Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1. Am. J. Pathol. 137: 135-147.
100. Berek, S. & Martinez-Maza, O. (1994) Molecular and biologic factors in the pathogenesis of ovarian cancer. J. Reprod. Med. 39: 241-248.
101. Kommoss, F., Wolfe, J., Bauknecht, T. et al. (1994) Co-expression of M-CSF transcripts and protein, FMS (M-CSF receptor) transcripts and protein, and steroid receptor content in adenocarcinomas of the ovary. J. Pathol. 174: 111-119.
102. Bauknecht, T., Kiechle-Schwarz, M., Du Bois, A., Wolfe, J. & Kacinski, B. (1994) Expression of transcripts for CFS-1 and for the 'macrophage' and 'epithelial' isoforms of the CSF-1R transcripts in human ovarian carcinomas. Cancer Detect. Prev. 18: 231-239.
103. Filderman, A. E., Bruckner, A., Kacinski, B. M., Deng, N. & Remold, H. G. (1992) Macrophage colony-stimulating factor (CSF-1) enhances invasiveness in CSF-1 receptor-positive carcinoma cell lines. Cancer Res. 52: 3661-3666.
104. Price, F. V., Chambers, S. K., Chambers, J. T. et al. (1993) Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survival. Am. J. Obstet. Gynecol. 168: 520-527.
105. Price, F. V., Chambers, S. K., Chambers, J. T. et al. (1993) Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survival. Am. J. Obstet. Gynecol. 168: 520-527.
106. Kutteh, W. H. & Kutteh, C. C. (1992) Quantitation of tumor necrosis factor-α, interleukin-1β and interleukin-6 in the effusions of ovarian epithelial neoplasms. Am. J. Obstet. Gynecol. 167: 1864-1869.
107. Moradi, M. M., Carson, L. F., Weinberg, B., Haney, A. F., Twiggs, L B. & Ramakrishnan, S. (1993) Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer. Cancer 72: 2433-2440.
108. Gastl, G., Plante, M., Finstad, C. L. et al. (1993) High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer. Br. J. Haematol. 83: 433-441.
109. Buick, R. N., Fry, S. E. & Salmon, S. E. (1980) Effect of host-cell interactions on clonogenic carcinoma cells in human malignant effusions. Br. J. Cancer 41: 695-704.
110. Mantovani, A., Peri, G., Polentarutti, N., Bolis, G., Mangioni, C. & Spreafico, F. (1979) Effects on in vitro tumor growth of macrophages isolated from human ascitic ovarian tumors. Int. J. Cancer 23: 157-164.
111. Salmon, S. E. & Hamburger, A. W. (1978) Immunoproliferation and cancer: a common macrophage-derived promoter substance. Lancet 1(8077): 1289-1290.
112. Vaage, J. & Agarwal, S. (1979) Endogenous tumor growth factor indicated by increased ornithine decarboxylase activity in malignant cells treated with host serum or ascites fluid. Cancer Res. 39: 1511-1517.
113. Uitendaal, M. P., Hubers, H. A. J. M., McVie, J. G. & Pinedo, H. M. (1983) Human tumour clonogenicity in agar is improved by cell-free ascites. Br. J. Cancer 48: 55-59.
114. Levine, A. E., Hamilton, D. A., Yeoman, L C., Busch, H. & Brattain, M. G. (1984) Identification of a tumor inhibitory factor in rat ascites fluid. Biochem. Biophys. Res. Commun. 119: 76-82.
115. Wilson, A. P., Fox, H., Scott, I. V., Lee, H., Dent, M. & Golding, P. R. (1991) A comparison of the growth promoting properties of ascitic fluids, cyst fluids and peritoneal fluids from patients with ovarian tumours. Br. J. Cancer 63: 102-108.
116. Mills, G. B., May, C., McGill, M., Roifman, C. M. & Mellors, A. (1988) A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action. Cancer Res. 48: 1066-1071.
117. Mills, G. B., May, C., Hill, M., Campbell, S., Shaw, P. & Marks, A. (1990) Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells. J. Clin. Invest. 86: 851-855.
118. Xu, Y. & Mills, G. B. (1995) Activation of human ovarian cancer cells: role of lipid factors in ascitic fluid. In: Sharp, F., Mason, P., Blackett, T. & Berek, J. eds, Ovarian Cancer 3, 1st edition. London: Chapman & Hall Medical, pp. 121-135.
119. Hanahan, D. J. (1986) Platelet activating factor: a biologically active phosphoglyceride. Annu. Rev. Biochem. 55: 438-509.
120. Chao, W. & Olson, M. S. (1993) Platelet-activating factor: receptors and signal transduction. Biochem. J. 292: 617-629.
121. Bussolino, F. & Canussi, G. (1995) Platelet-activating factor produced by endothelial cells. A molecule with autocrine and paracrine properties. Eur. J. Biochem. 229: 327-337.
122. Bishop, W. R. & Bell, R. M. (1988) Assembly of phospholipids into cellular membranes: biosynthesis, transmembrane movement and intracellular translocation. Annu. Rev. Cell. Biol. 4: 579-610.
123. Jalink, K., Hordijk, P. L. & Moolenaar, W. H. (1994) Growth factor-like effects of lysophosphatidic acid, a novel lipid mediator. Biochim. Biophys. Acta 1198: 185-196.
124. Van der Bend, R. L., Brunner, J., Jalink, K., Van Corven, E. J., Moolenaar, W. H. & Van Blitterswijk, W. J. (1992) Identification of a putative membrane receptor for the bioactive phospholipid, lysophosphatidic acid. EMBO 11: 2495-2501.
125. Tigyi, G. & Miledi, R. (1992) Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells. J. Biol. Chem. 267: 21360-21367.
126. Kreps, D. M., Whittle, S. M., Huffman, J. M. & Toews, M. L (1993) Lysophosphatidic acid mimics serum-induced sensitization of cyclic AMP accumulation. FASEB J. 7: 1376-1380.
127. Jalink, K. & Moolenaar, W. H. (1992) Thrombin receptor activation causes rapid neural cell rounding and neurite retraction independent of classic second messengers. J. Cell. Biol. 118: 411-419.
128. Moolenaar, W. H. (1994) LPA: a novel lipid mediator with diverse biological action. Trends Cell Biol. 4: 213-219.
129. Cowan, D. H. & Graham, J. (1983) Stimulation of human tumor colony formation by platelet lysate. J. Lab. Clin. Med. 102: 973-986.
130. Cowan, D. H., Graham, J., Paskevich, M. C. & Quinn, P. G. (1983) Influence of platelet lysate on colony formation of human breast cancer cells. Breast Cancer Res. Treatm. 3: 171-178.
131. Childs C. B., Proper, J. A., Tucker, R. F. & Moses, H. L. (1982) Serum contains a platelet-derived transforming growth factor. Proc. Natl. Acad. Sci. USA 79: 5312-5316.
132. Van Corven, E. J., Groenink, A., Jalink, K., Eichholtz, T. & Moolenaar, W. H. (1989) Lysophosphatidate-induced cell proliferation: identification and dissection of signalling pathways mediated by G proteins. Cell 59: 45-54.
133. Van Corven, E. J., Van Rijswijk, A., Jalink, K., Van der Bend, R. L, Van Blitterswijk, W. J. & Moolenaar, W. H. (1992) Mitogenic action of lysophosphatidic acid and phsophatidic acid on fibroblasts. Biochem. J. 281: 163-169.
134. Imamura, F., Horai, T., Mukai, M., Shinkai, K., Sawada, M. & Akedo, H. (1993) Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D. Biochem. Biophys. Res. Commun. 193: 497-503.
135. Xu, Y., Casey, G. & Mills, G. B. (1995) Effect of lysophospholipids on signaling in the human Jurkat T cell line. J. Cell. Physiol. 163: 441-450.
136. Xu, Y., Fang, X.-J., Casey, G. & Mills, G. B. (1995) Lysophospholipids activate ovarian and breast cancer cells. Biochem. J. 309: 933-940.
137. Moolenaar, W. H. (1995) Lysophosphatidic acid signalling. Curr. Opin. Cell. Biol. 7: 203-210.